GLP-1 drugs like Ozempic and Zepbound treat diseases related to blood sugar and weight management. Professor Joe Balagtas ...

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

For people with obstructive sleep apnea, Zepbound should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said. The US Food and Drug Administration on ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment ... be combined with a reduced-calorie diet and increased physical activity.

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

Lilly’s decision to offer vials has also been seen as its way to combat the rise in compounding. Patients have been turning ...

Eli Lilly's stock tumbled 8% on Tuesday after it forecast fourth-quarter sales of weight-loss drug Zepbound below Wall Street ...

The FDA said the popular weight-loss drug should be combined with a reduced-calorie diet and increased physical activity. An injection pen of Zepbound ... a treatment for people with moderate ...

was cleared to treat moderate to severe forms of the sleep condition in people with obesity. It should be used with a reduced-calorie diet and increased physical activity, drugmaker Eli Lilly said ...

"The approval is the second indication for Zepbound ... forms of the sleep condition in people with obesity. It should be used with a reduced-calorie diet and increased physical activity ...